Álvarez ZD, Valdés AL, Santana BO, Lugo AJ

Language: Spanish
References: 26
Page:
PDF size: 75.85 Kb.

ABSTRACT

Introduction: the child of a diabetic mother (CDM) can suffer alterations during pregnancy by this maternal disease. When it appears in the second half of gestation, we talk of diabetic foetopathy, which is more frequent in women with uncontrolled metabolic and gestational diabetes mellitus (GDM). Age, parity, obesity, weight gain during pregnancy, degree of glucose intolerance, among others, can influence fetal growth determinants. The research sought to understand the relationship of these factors with birth weight.
Objective: to identify modifiable factors, which increase the frequency of newborns with appropriate weight for gestational age in diabetic pregnant women.
Methods: results are analyzed in 2 038 live births born from diabetic mothers (350 diabetic pre-gestational and diabetic gestational 1 688), during 14 years.
Results: occurrence of excess neonatal weight was 11.83%, its reduction was achieved, but with no increase in weight. No significant differences were observed in the frequency of excess body weight among pre-gestational and gestational diabetic patients. Neonatal overweight is associated with parity, maternal pre- pregnancy overweight, excessive weight gain and degree of metabolic control during pregnancy. Underweight was associated with low maternal weight before pregnancy, gestational hypertensive disease and mother vascular glomerular injury.
Conclusion: the excess or low weights in infants in relation with their gestational age were associated with different risk factors.

REFERENCES

1. White P. Pregnancy and Diabetes. Medical aspects. Med Clin North Am. 1965;49:54.

2. Pendersen J. The pregnant diabetic and her newborn. (20th edition). Baltimore: Williams and Wilkins; 1997. p. 22-45.

3. Joppich G, Sculte F. Diversas formas de lesión fetal en la diabetes de la madre. En: Neurología del Recién Nacido. 2da. ed. Madrid: Ed. Paz Montalvo; 1973. p. 250.

4. Valdés Amador L, Márquez Guillén A. La macrosomía y el gigantismo en hijos de madres diabéticas. Rev Cubana Obstet Ginecol. 1989;15(3):129-39.

5. Espinosa de los Monteros Mena A, Ramírez Torres A. Diabetes y embarazo. En: Ahued JR, Fernández del Castillo C, Bailon Uriza R. Ginecología y Obstetricia Aplicadas. 2da. ed. Cap 44. México: Editorial El Manual Moderno; 2003. p. 491-98.

6. Williams. Tratado de Obstetricia. 21ra. edic. Capítulo 51. La Habana: Editorial Ciencias médicas (ECIMED); 2007.

7. American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care. Jan 2007;30 Suppl 1:S4-S41.

8. Valdés Amador L, Santana Bacallao O, Márquez Guillén A, Rodríguez Anzardo B. Parameter analysis related with newborn weight in children of diabetic mothers. Study or 1 320 alive deliveries. The International Association of the Diabetes and Pregnancy Study Group. Abstract Book. p. 130, August 29 to sept 2, Spain 2003.

9. Yajnik CS. Early life origin of insulin resistance and type 2 diabetes in Indian and other Asian countries. J Nutr. 2004;134(1):205-10.

10. Márquez Guillén A, Valdés Amador L, Güell González R. Diabetes y Embarazo. Serie Orientaciones Terapéuticas. Ginecología. Volumen 1. La Habana: CNICM; 1968.

11. Thompson DJ. Prophylactic insulin treatment of gestacional diabetes. Obstet Gynecol. 1990;75:960-4.

12. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications. WHO/NCD/NCS:2; 1999.

13. Dueñas Gómez E, Sánchez Texido C, Santurio Gil E. Patrones Antropométricos en el Recién Nacido. La Habana: ECIMED; 1991.

14. Valdés Amador L. Estudio comparativo entre la diabetes mellitus gestacional y la tolerancia a la glucosa alterada. En: Saavedra J. Trabajo de Terminación de la Residencia en Ginecobstetricia. La Habana: Hospital Docente "Ramón González Coro"; 1990.

15. Manual de procedimientos de diagnóstico y tratamiento en Pediatría. La Habana: Edit. Pueblo y Educación; 1986.

16. Thompson DJ. Prophylactic insulin treatment of gestacional diabetes. Obstet Gynecol. 1990;75:960-4.

17. American Diabetes Association (ADA). Medical management of Pregnancy complicated by Diabetes. Education Series. Alexandria. Second Edition. 22314; 1995. p. 45-55.

18. Oded Langer, Yariv Yogev, Elly Xenakis, Barak Rosenn. Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcome. American Journal of Obstetrics and Gynecology. 2005;192:134-9.

19. Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit. 2006;28:67-72.

20. Sutherland HW. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. Br medical J. 1973:9-13.

21. Soto NY, Mericg V. Restricción del crecimiento fetal e insulino-resistencia. Nuevos hallazgos y revisión de la literatura. Rev Med Chile. 2005;133:97-104.

22. Sanmarti A. Asociación de bajo peso al nacer con el riesgo de diabetes mellitus en la edad adulta. Nutric y Obesidad; 2003:56-9.

23. Metzger BE, Coustan DR. The Organizing Committee: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes care. 1998;21(Suppl. 2):B161-7.

24. Márquez A, Aldana D, González ME, Lang J, Pérez L, Valdés L, et al. Prevalencia de Diabetes Gestacional en un área de salud de Ciudad de la Habana. Rev A.L.A.D. 1996;4:75-80.

25. Reichelt AJ, Spichler ER, Branchtein L, Nucci LB, Franco LJ, Scmidt MI. Fasting plasma glucose is a useful test for the detection of gestacional diabetes. Diabetes Care. 1998;21:1246-9.

26. Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. Nov 2004;191(5):1655-60.